On the contrary, in the male subset, the PDE5 serum level increased in subjects with prostatic diseases (Fig. 2): the Scheffé test for all pairwise comparisons showed statistically significantly higher PDE5 levels only for PCa compared to both BPH and male controls. The gene discussed is PDE5A; the disease is posterior cortical atrophy.